Medicare Part D will cover popular weight loss drugs like Wegovy and Ozempic starting in 2026, with copays capped at $50 per ...

Wegovy jab users face regaining the weight they have lost, with patients finding themselves blocked from getting further ...

Target has expanded its protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand ...

Eli Lilly said on Thursday its next-generation obesity drug helped patients lose an average of 28.7% of their weight in a ...

In an added benefit, more than one in eight people taking the highest dose of Retratrutide were completely free of arthritic ...

Ozempic and Wegovy, have lately, become popular weight-loss drugs. Recent research shows how these drugs can work on the brain to control hunger, cravings, and thirst. The findings could help people ...

Zepbound (tirzepatide) and Wegovy (semaglutide) are FDA-approved injectable medications revolutionizing weight management. Both belong to the incretin mimetic drug class but differ in their mechanisms ...

Researchers say new compound improves metabolic activity within muscles instead of acting on hunger pathways like Ozempic and ...

The European Medicines Agency (EMA) has issued a positive opinion for a new Wegovy® 7.2 mg dose, advancing its availability ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed ...